Kalyan, Shirin http://orcid.org/0000-0002-7332-2225
Bazett, Mark
Sham, Ho Pan
Bosiljcic, Momir
Luk, Beryl
Dhanji, Salim
Costa, Amanda M.
Wong, Stephanie W. Y.
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Mullins, David W. http://orcid.org/0000-0002-2644-350X
Gunn, Hal
Funding for this research was provided by:
National Research Council of Canada-IRAP Program; Qu Biologics
Article History
Received: 27 November 2019
Accepted: 17 March 2020
First Online: 3 April 2020
Competing interests
: All authors except A.M.C., D.W.M. and M.G.N. are or were employees of Qu Biologics. S.K. is also a faculty member of the Department of Medicine at the University of British Columbia. Hal Gunn is the CEO and co-founder of Qu Biologics. D.W.M. has received consulting fees and funding for contract research from Qu Biologics. The authors have no additional competing interests to disclose.